Japan Precision Oncology Market Size & Outlook, 2024-2030

The precision oncology market in Japan is expected to reach a projected revenue of US$ 15,161.7 million by 2030. A compound annual growth rate of 11.3% is expected of Japan precision oncology market from 2025 to 2030.
Revenue, 2024 (US$M)
$7,997.6
Forecast, 2030 (US$M)
$15,161.7
CAGR, 2025 - 2030
11.3%
Report Coverage
Japan

Japan precision oncology market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan precision oncology market, 2018-2030 (US$M)

Japan precision oncology market highlights

  • The Japan precision oncology market generated a revenue of USD 7,997.6 million in 2024 and is expected to reach USD 15,161.7 million by 2030.
  • The Japan market is expected to grow at a CAGR of 11.3% from 2025 to 2030.
  • In terms of segment, therapeutics was the largest revenue generating product in 2024.
  • Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.


Precision oncology market data book summary

Market revenue in 2024USD 7,997.6 million
Market revenue in 2030USD 15,161.7 million
Growth rate11.3% (CAGR from 2025 to 2030)
Largest segmentTherapeutics
Fastest growing segmentDiagnostics
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostics, Therapeutics
Key market players worldwideThermo Fisher Scientific Inc, Invitae Corp, Qiagen NV, Illumina Inc, Exact Sciences Corp, Rain Oncology, Strata Oncology, Xilis, Variantyx, BioServe, Relay Therapeutics, Acrivon Therapeutics


Other key industry trends

  • In terms of revenue, Japan accounted for 6.9% of the global precision oncology market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan precision oncology market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,900.9 million by 2030.

Therapeutics was the largest segment with a revenue share of 79% in 2024. Horizon Databook has segmented the Japan precision oncology market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.


The precision oncology market in Japan is anticipated to grow at a significant CAGR during the forecast period. Japan’s investment in research and development, particularly in biotechnology and diagnostics, supports continuous innovation and market growth.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Precision Oncology Market Companies

Name Profile # Employees HQ Website

Japan precision oncology market size, by product, 2018-2030 (US$M)

Japan Precision Oncology Market Outlook Share, 2024 & 2030 (US$M)

Japan precision oncology market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more